Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Share News (MCS)

  • There is currently no data for MCS

Wednesday broker round-up

Wed, 15th Jul 2020 12:24
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.



Ocado Group: Berenberg reiterates buy with a target price of 2,225.0p.

DFS: Berenberg reiterates buy with a target price of 210.0p.

Atalaya Mining: Canaccord reiterates buy with a target price of 220.0p.

McCarthy & Stone: Canaccord reiterates hold with a target price of 82.0p.

Ferrexpo: JP Morgan downgrades to underweight with a target price of 150.0p.

GlaxoSmithKline: Citigroup reiterates neutral.

Auto Trader Group: Deutsche Bank reiterates buy with a target price of 680.0p.

London Stock Exchange: Deutsche Bank reiterates hold with a target price of 7,700.0p.

Legal & General Group: Deutsche Bank reiterates buy with a target price of 290.0p.

Senior: Barclays reiterates underweight with a target price of 45.0p.

Marks & Spencer Group: Barclays reiterates overweight with a target price of 140.0p.

Fevertree Drinks: Liberum reiterates buy with a target price of 2,570.0p.

Big Yellow Group: Liberum reiterates hold with a target price of 1,000.0p.

Dunelm Group: Peel Hunt reiterates buy with a target price of 1,400.0p.

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
2 days ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
2 days ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
2 days ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

MCS.L News

Housebuilders are too cheap, Jefferies says
19 Mar 2020

Housebuilders are too cheap, Jefferies says

(Sharecast News) - UK housebuilders are too cheap, Jefferies said as the broker placed 'buy' ratings on almost all sector stocks after big share price...

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy
19 Mar 2020

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy

UK Shareholder Meetings Calendar - Next 7 Days
18 Mar 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

McCarthy & Stone scraps dividend due to outbreak
18 Mar 2020

McCarthy & Stone scraps dividend due to outbreak

(Sharecast News) - Retirement housebuilder McCarthy & Stone said on Wednesday that the coronavirus would have a "material" impact on trading in th...

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus
18 Mar 2020

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus

UK Dividends Calendar - Next 7 Days
27 Feb 2020

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold
20 Feb 2020

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold

Friday broker round-up
7 Feb 2020

Friday broker round-up

(Sharecast News) - Vodafone: Jefferies upgrades to buy with a target price of 146p.